LIGAND PHARMACEUTICALS INC's ticker is and the CUSIP is 53220KAF5. A total of 31 filers reported holding LIGAND PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $10,619,788 | -48.3% | 10,697,000 | -49.0% | 0.12% | -45.8% |
Q4 2022 | $20,534,756 | +9.1% | 20,994,000 | +8.4% | 0.22% | +4.3% |
Q3 2022 | $18,828,000 | -4.4% | 19,361,000 | -5.4% | 0.21% | -9.6% |
Q2 2022 | $19,704,000 | -0.9% | 20,472,000 | +0.6% | 0.23% | +10.6% |
Q1 2022 | $19,882,000 | +6.4% | 20,353,000 | +9.0% | 0.21% | +1.5% |
Q4 2021 | $18,683,000 | -7.4% | 18,672,000 | -6.8% | 0.20% | -27.7% |
Q3 2021 | $20,172,000 | +9.8% | 20,037,999 | +8.6% | 0.28% | +14.2% |
Q2 2021 | $18,372,000 | +15.5% | 18,449,999 | +20.9% | 0.25% | +11.8% |
Q1 2021 | $15,908,000 | -0.1% | 15,259,000 | -9.2% | 0.22% | -19.3% |
Q4 2020 | $15,931,000 | -6.0% | 16,797,000 | -9.8% | 0.27% | -25.5% |
Q3 2020 | $16,940,000 | -2.9% | 18,629,000 | -6.0% | 0.37% | -4.9% |
Q2 2020 | $17,437,000 | +11.6% | 19,826,000 | +5.1% | 0.39% | -11.8% |
Q1 2020 | $15,622,000 | -24.5% | 18,865,000 | -21.1% | 0.44% | +12.6% |
Q4 2019 | $20,688,000 | +61.0% | 23,903,000 | +55.5% | 0.39% | +54.8% |
Q3 2019 | $12,849,000 | -24.5% | 15,368,000 | -21.8% | 0.25% | -21.0% |
Q2 2019 | $17,013,000 | – | 19,648,000 | – | 0.32% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|